Skip to main content
. 2024 Sep 3;56(4):473–482. doi: 10.3947/ic.2024.0031

Table 2. Microbiological characteristics of ST72 Staphylococcus aureus .

Characteristics Total (n=442) ST72 MSSA (n=157) ST72 MRSA (n=285) P
Antibiotics resistance
Clindamycin 64 (14.5) 6 (3.8) 58 (20.4) <0.01
Ciprofloxacin 24 (5.4) 2 (1.3) 22 (7.7) 0.01
Erythromycin 82 (18.6) 8 (5.1) 74 (26.0) <0.01
Fusidic acid 133 (30.1) 131 (83.4) 2 (0.7) <0.01
Gentamicin 50 (11.3) 14 (8.9) 36 (12.6) 0.31
Rifampin 7 (1.6) 2 (1.3) 5 (1.8) >0.99
TMP/SMX 2 (0.5) 0 2 (0.7) 0.54
Tetracycline 9 (2.0) 1 (0.6) 8 (2.8) 0.17
Vancomycin MIC by BMD method <0.01
0.5 8 (1.8) 3 (1.9) 5 (1.8)
1 391 (88.5) 152 (96.8) 239 (83.9)
2 43 (9.7) 2 (1.3) 41 (14.4)
Vancomycin MIC by E test method <0.01
0.5 9 (2.0) 9 (5.7) 0
0.75 30 (6.8) 23 (14.6) 7 (2.5)
1 110 (24.9) 54 (34.4) 56 (19.6)
1.5 221 (50.0) 61 (38.9) 160 (56.1)
2 68 (15.4) 10 (6.4) 58 (20.4)
3 4 (0.9) 0 4 (1.4)
agr group 0.69
I 436 (98.6) 155 (98.7) 281 (98.6)
II 1 (0.2) 0 1 (0.4)
III 1 (0.2) 0 1 (0.4)
Not determined 4 (0.9) 2 (1.3) 2 (0.7)
agr dysfunction 62 (14.0) 31 (19.7) 31 (10.9) 0.02
spa typesa <0.01
t324 145 (32.8) 11 (7.0) 134 (47.0)
t126 106 (24.0) 104 (66.2) 2 (0.7)
t664 45 (10.2) 2 (1.3) 43 (15.1)
t148 34 (7.7) 3 (1.9) 31 (10.9)
t2461 9 (2.0) 1 (0.6) 8 (2.8)
t2431 7 (1.6) 0 7 (2.5)
others 87 (19.7) 30 (19.1) 57 (20.0)

Data are the number of patients (%).

aOnly spa types with more than 5 cases are shown.

ST, sequence type; MSSA, methicillin-susceptible Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus; TMP/SMX, trimethoprim/sulfamethoxazole; MIC, minimal inhibitory concentration; BMD, broth microdilution.